2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2005247589 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bossenmaier, Birgit; Friebe, WalterGunar; Georges, Guy; Geletneky, Christian; Kolm, Irene; Friess, Thomas; Voss, Edgar

Agent Davies Collison Cave

Pub. Number AU-A-2005247589

PCT Pub. Number WO2005/116020

Priority 04012295.4 25.05.04 EP

Filing date 24 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/116020 Priority application(s): WO2005/116020

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247598-Tumor-associated peptides that bind to MHC-molecules

2005247588-Thioether derivatives, their manufacture and use as pharmaceutical agents